TY - JOUR
T1 - Formation of Cyclic 1, N2-Adducts by Reaction of Deoxyguanosine wit α-Acetoxy-N-nitrosopyrrolidine, 4-(Carbethoxynitrosamino)butanal, or Crotonaldehyde
AU - Chung, Funa Lung
AU - Hecht, Stephen S.
PY - 1983/3/1
Y1 - 1983/3/1
N2 - The structures of the DNA adducts formed in the metabolism of cyclic N-nitrosamines are not known. To approach this problem, we studied the reactions with deoxyguanosine, catalyzed by porcine liver esterase, of α-acetoxy-N-nitrosopyrrolidine and 4-(carbethoxynitrosamino)butanal which are stable precursors to the reactive intermediates, α-hydroxy-N-nitrosopyrrolidine and 3-formy1-1propanediazohydroxide formed in the a-hydroxylation of the cyclic nitrosamine, N-nitrosopyrroli-dine. The same two major deoxyguanosine adducts were produced in each reaction. They were isolated by high-performance liquid chromatography and characterized by their ultraviolet spectra, mass spectra, and proton magnetic resonance spectra. On the basis of these spectral data, the structures of the two major adducts were assigned as 3-(2-deoxy-ß-D-ery-thropentofuranosyl)-5,6,7,8-tetrahydro-8R-hydroxy-6R-methylpyrimido [1,2-a]purine-10(3H)one and 3-(2-deoxy-ß-D-ery-thro-pentofuranosyl)-5,6,7,8-tetrahydro-8S-hydroxy-6S-methylpyrimido[1,2-a]purine-10(3H)one, in which a new saturated six-membered ring is formed by reaction at the 1- and Appositions of deoxyguanosine. The same two adducts were formed in the reaction of crotonaldehyde (2-butenal) with deoxyguanosine. Mild acid hydrolysis of each of the two diastereomeric deoxyguanosine adducts yielded a pair of enantiomeric tricyclic 1, N2-guanine derivatives which had spectral properties in accordance with the assigned structures. Treatment of these tricyclic 1, N2-guanine derivatives with NaOH and NaBH4 yielded N2-(3-hydroxy-1-methylpropyl)guanine, confirming the structural assignments. The results of this study demonstrate that, unlike saturated dialkylnitrosamines which are metabolized to intermediates that give mainly 7-alkylation of deoxyguanosine, the intermediates formed in the α-hydrox-ylation of a cyclic nitrosamine, N2-nitrosopyrrolidine, modify deoxyguanosine by forming cyclic 1, N2-adducts.
AB - The structures of the DNA adducts formed in the metabolism of cyclic N-nitrosamines are not known. To approach this problem, we studied the reactions with deoxyguanosine, catalyzed by porcine liver esterase, of α-acetoxy-N-nitrosopyrrolidine and 4-(carbethoxynitrosamino)butanal which are stable precursors to the reactive intermediates, α-hydroxy-N-nitrosopyrrolidine and 3-formy1-1propanediazohydroxide formed in the a-hydroxylation of the cyclic nitrosamine, N-nitrosopyrroli-dine. The same two major deoxyguanosine adducts were produced in each reaction. They were isolated by high-performance liquid chromatography and characterized by their ultraviolet spectra, mass spectra, and proton magnetic resonance spectra. On the basis of these spectral data, the structures of the two major adducts were assigned as 3-(2-deoxy-ß-D-ery-thropentofuranosyl)-5,6,7,8-tetrahydro-8R-hydroxy-6R-methylpyrimido [1,2-a]purine-10(3H)one and 3-(2-deoxy-ß-D-ery-thro-pentofuranosyl)-5,6,7,8-tetrahydro-8S-hydroxy-6S-methylpyrimido[1,2-a]purine-10(3H)one, in which a new saturated six-membered ring is formed by reaction at the 1- and Appositions of deoxyguanosine. The same two adducts were formed in the reaction of crotonaldehyde (2-butenal) with deoxyguanosine. Mild acid hydrolysis of each of the two diastereomeric deoxyguanosine adducts yielded a pair of enantiomeric tricyclic 1, N2-guanine derivatives which had spectral properties in accordance with the assigned structures. Treatment of these tricyclic 1, N2-guanine derivatives with NaOH and NaBH4 yielded N2-(3-hydroxy-1-methylpropyl)guanine, confirming the structural assignments. The results of this study demonstrate that, unlike saturated dialkylnitrosamines which are metabolized to intermediates that give mainly 7-alkylation of deoxyguanosine, the intermediates formed in the α-hydrox-ylation of a cyclic nitrosamine, N2-nitrosopyrrolidine, modify deoxyguanosine by forming cyclic 1, N2-adducts.
UR - http://www.scopus.com/inward/record.url?scp=0020686618&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0020686618&partnerID=8YFLogxK
M3 - Article
C2 - 6825094
AN - SCOPUS:0020686618
SN - 0008-5472
VL - 43
SP - 1230
EP - 1235
JO - Cancer Research
JF - Cancer Research
IS - 3
ER -